Skip to main content
OpenTrials
Completed

NCT Number: NCT04859595

Follow-up After a Stay in Intensive Rehabilitation for Patients With Swallowing Disorders

Prospective, open-label, randomized, single-center study evaluating the benefit of a months long monthly telephone follow-up for patients with chronic disorders following the after-effects of anti-cancer treatments after an intensive rehabilitation stay versus standard follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Toulouse

Toulouse, France

About this study

Upper aerodigestive tract (UAT) cancer is a malignant tumor in the hypopharynx, larynx, oropharynx and oral cavity. In 2017, 15,000 new cases of cancers of the upper aero-digestive tract were identified: which in France places them among the most frequent cancers.

The treatments used to treat UAT cancers are of three types: surgery, radiotherapy and radio chemotherapy and can have significant functional consequences, in particular on swallowing and phonation.

This therapeutic management is routinely associated with supportive care, in order to ensure the functional rehabilitation that will allow the maintenance of the quality of life of these patients as well as their entourage by reducing the side effects of the treatments and the effects of disease.

Intensive rehabilitation is offered to patients who have been treated for UAT cancer in order to speed up the learning of new behaviors and improve their memorization. Thus, these patients benefit from intensive multidisciplinary rehabilitation within the Intensive Reeducation Center for Laryngectomees.

However, it is not uncommon to see patients return for a second stay following a loss of the benefits learned, in particular on the swallowing function, omissions of food safety instructions or an interruption of local rehabilitation.

Studies have shown that remote monitoring can have a positive impact on the health of these patients. However, no study has assessed the impact of such monitoring on functional swallowing abilities.

This study will asses the impact of a monthly phone call during 6 months on patients with chronic swallowing disorders compared to the routine follow up. The telephone interviews will mainly consist of questionnaires.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients treated for cancer of the upper aero-digestive tract
  • Patients who have stayed at the intensive laryngectomee rehabilitation center CRIL
  • Patients with a medical diagnosis of swallowing disorders at risk of inhalation (i.e. a Penetration Aspiration Scale score ≥5)
  • Informed consent signed by the patient.
  • Patients with social security or equivalent
  • Patient who does not need intensive speech therapy when leaving the rehabilitation center or only benefits from one rehabilitation session per week

Exclusion criteria

  • Progressive neurological disease leading to cognitive disorders (MOntreal Cognitive Assessment ≤ 17)
  • Patient under guardianship, curator or legal protection
  • Inability to provide the person with enlightened information and to ensure the subject's compliance due to impaired physical and / or psychological health,
  • Patient who cannot be reached by telephone or does not have a telephone line
  • Patient participating in another research including an exclusion period still in progress
  • Patient whose state of health on leaving the rehabilitation center requires intensive town speech therapy for more than 1 rehabilitation session per week

Treatment and study plan

Telephone Follow-up

Other

Monthly follow-up by telephone from M1 to M6. The interview will unroll in 2 stages, a first stage of discussion during which the speech therapist will take news of the patient. The second, more formal phase will be the opportunity to collect the data necessary for the validation of the primary and secondary outcomes. To do this, the speech therapist will use the Functional Oral Intake Scale (FOIS) score, the DHI and an interview grid.

The interview will be conducted using an interview sheet previously written by the project team. The following elements will be discussed: the description of oral food intakes (TIMES), the perceived swallowing handicap (DHI), the instructions related to the diet and their daily application, ongoing rehabilitation follow-ups, notable events as well, then his emotional and psychological experience in relation to the disorder.

Primary outcomes

  1. Maintenance of functional capacities

    Time frame: Baseline T0 : At the end of the initial routine reeducation intervention

    Assessed by establishing the FOIS (Functional Oral Intake Scale) score :

    Level from 1 to 7, (1 being the worse functional oral intake, 7 being the best functional oral intake possible)

    TUBE DEPENDENT (levels 1-3)

    • No oral intake
    • Tube dependent with minimal/inconsistent oral intake
    • Tube supplements with consistent oral intake TOTAL ORAL INTAKE (levels 4-7)
    • Total oral intake of a single consistency
    • Total oral intake of multiple consistencies requiring special preparation
    • Total oral intake with no special preparation, but must avoid specific foods or liquid items
    • Total oral intake with no restrictions
  2. Maintenance of functional capacities

    Time frame: T1M : 1 month after Baseline T0 (the end of the routine reeducation intervention)

    Assessed by establishing the FOIS (Functional Oral Intake Scale) score :

    Level from 1 to 7 :

    TUBE DEPENDENT (levels 1-3)

    • No oral intake
    • Tube dependent with minimal/inconsistent oral intake
    • Tube supplements with consistent oral intake TOTAL ORAL INTAKE (levels 4-7)
    • Total oral intake of a single consistency
    • Total oral intake of multiple consistencies requiring special preparation
    • Total oral intake with no special preparation, but must avoid specific foods or liquid items
    • Total oral intake with no restrictions
  3. Maintenance of functional capacities

    Time frame: T2M : 2 months after Baseline T0 (the end of the routine reeducation intervention)

    Assessed by establishing the FOIS (Functional Oral Intake Scale) score :

    Level from 1 to 7 :

    TUBE DEPENDENT (levels 1-3)

    • No oral intake
    • Tube dependent with minimal/inconsistent oral intake
    • Tube supplements with consistent oral intake TOTAL ORAL INTAKE (levels 4-7)
    • Total oral intake of a single consistency
    • Total oral intake of multiple consistencies requiring special preparation
    • Total oral intake with no special preparation, but must avoid specific foods or liquid items
    • Total oral intake with no restrictions
  4. Maintenance of functional capacities

    Time frame: T3M : 3 months after Baseline T0 the end of the routine reeducation intervention

    Assessed by establishing the FOIS (Functional Oral Intake Scale) score :

    Level from 1 to 7 :

    TUBE DEPENDENT (levels 1-3)

    • No oral intake
    • Tube dependent with minimal/inconsistent oral intake
    • Tube supplements with consistent oral intake TOTAL ORAL INTAKE (levels 4-7)
    • Total oral intake of a single consistency
    • Total oral intake of multiple consistencies requiring special preparation
    • Total oral intake with no special preparation, but must avoid specific foods or liquid items
    • Total oral intake with no restrictions
  5. Maintenance of functional capacities

    Time frame: T4M : 4 months after Baseline T0 the end of the routine reeducation intervention

    Assessed by establishing the FOIS (Functional Oral Intake Scale) score :

    Level from 1 to 7 :

    TUBE DEPENDENT (levels 1-3)

    • No oral intake
    • Tube dependent with minimal/inconsistent oral intake
    • Tube supplements with consistent oral intake TOTAL ORAL INTAKE (levels 4-7)
    • Total oral intake of a single consistency
    • Total oral intake of multiple consistencies requiring special preparation
    • Total oral intake with no special preparation, but must avoid specific foods or liquid items
    • Total oral intake with no restrictions
  6. Maintenance of functional capacities

    Time frame: T5M : 5 months after Baseline T0 the end of the routine reeducation intervention

    Assessed by establishing the FOIS (Functional Oral Intake Scale) score :

    Level from 1 to 7 :

    TUBE DEPENDENT (levels 1-3)

    • No oral intake
    • Tube dependent with minimal/inconsistent oral intake
    • Tube supplements with consistent oral intake TOTAL ORAL INTAKE (levels 4-7)
    • Total oral intake of a single consistency
    • Total oral intake of multiple consistencies requiring special preparation
    • Total oral intake with no special preparation, but must avoid specific foods or liquid items
    • Total oral intake with no restrictions
  7. Maintenance of functional capacities

    Time frame: T6M : 6 months after BaselineT0 the end of the routine reeducation intervention

    Assessed by establishing the FOIS (Functional Oral Intake Scale) score:

    Level from 1 to 7 :

    TUBE DEPENDENT (levels 1-3)

    • No oral intake
    • Tube dependent with minimal/inconsistent oral intake
    • Tube supplements with consistent oral intake TOTAL ORAL INTAKE (levels 4-7)
    • Total oral intake of a single consistency
    • Total oral intake of multiple consistencies requiring special preparation
    • Total oral intake with no special preparation, but must avoid specific foods or liquid items
    • Total oral intake with no restrictions

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Collaborators

  • Fondation de l'Avenir

Registry information

Official study title

Benefit of an at Home Telephone Follow-up After a Stay in an Intensive Rehabilitation Center for Patients With Chronic Swallowing Disorders Following a Upper Aero-digestive Tract Cancer Treatment : Open, Controlled, Randomized Study

Acronym: E-CRIL

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Apr 26, 2021
Registry last updated
Aug 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.